Back to top

Legend Biotech downgraded at Oppenheimer on CEO exit, competition

Legend Biotech downgraded at Oppenheimer on CEO exit, competition

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Gilead Sciences, Inc. (GILD)

Johnson & Johnson (JNJ)

Legend Biotech Corporation Sponsored ADR (LEGN)

Ligand Pharmaceuticals Incorporated (LGND)